We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 1113 (+2)

2% more funds holding

Funds holding: 283288 (+5)

0.07% more ownership

Funds ownership: 94.92%94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M
Name Holding Trade Value Shares
Change
Change in
Stake
Comerica Bank
126
Comerica Bank
Texas
$1.11M -$103K -1,111 -8%
EPM
127
Equitec Proprietary Markets
Illinois
$1.1M -$334K -3,600 -23%
FIA
128
FNY Investment Advisers
New York
$1.1M +$1.11M +12,000 New
TRSOTSOK
129
Teachers Retirement System of the State of Kentucky
Kentucky
$1M
BPCE
130
Bank Pictet & Cie (Europe)
Germany
$998K
Tudor Investment Corp
131
Tudor Investment Corp
Connecticut
$980K -$15M -161,556 -94%
TCM
132
Teza Capital Management
Illinois
$975K +$529K +5,700 +116%
Bank of Montreal
133
Bank of Montreal
Ontario, Canada
$966K +$575K +6,197 +146%
TRCT
134
Tower Research Capital (TRC)
New York
$955K +$428K +4,617 +80%
Barclays
135
Barclays
United Kingdom
$954K -$2.96M -31,915 -75%
AGM
136
Alpine Global Management
New York
$918K
MTCM
137
Mint Tower Capital Management
Netherlands
$918K +$928K +10,000 New
SEI Investments
138
SEI Investments
Pennsylvania
$871K -$180K -1,940 -17%
LSERS
139
Louisiana State Employees Retirement System
Louisiana
$845K -$18.6K -200 -2%
ASRS
140
Arizona State Retirement System
Arizona
$840K +$16.4K +177 +2%
LCM
141
Legato Capital Management
California
$825K
ECU
142
Eisler Capital (US)
New York
$813K +$103K +1,115 +14%
Jane Street
143
Jane Street
New York
$786K +$474K +5,111 +148%
EBSAM
144
Eubel Brady & Suttman Asset Management
Ohio
$775K +$313K +3,368 +66%
Simplex Trading
145
Simplex Trading
Illinois
$774K +$782K +8,433 New
Wells Fargo
146
Wells Fargo
California
$763K -$2.31M -24,867 -75%
HH
147
Hilltop Holdings
Texas
$758K -$1.67K -18 -0.2%
BNP Paribas Financial Markets
148
BNP Paribas Financial Markets
France
$730K -$381K -4,102 -34%
Thrivent Financial for Lutherans
149
Thrivent Financial for Lutherans
Minnesota
$724K -$27.2K -293 -4%
SOMRS
150
State of Michigan Retirement System
Michigan
$723K -$9.28K -100 -1%

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.